Chromosomal abnormalities in marrow stromal cells from myelodysplastic syndromes (MDS) [1]

Blood

Volumn 108, Issue 12, 2006, Pages 3948-

  Flores Figueroa, Eugenia ^b   Mayani, Hector ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME ABERRATION; DNA REPAIR; GENETIC DAMAGE; GENETIC MARKER; HUMAN; KARYOTYPE; LETTER; MESENCHYME; MICROENVIRONMENT; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; STROMA CELL;

EID: 33845267781     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2006-08-040618     Document Type: Letter

References (5)

1. Ramakrishnan A, Awaya N, Bryant E, Torok-Storb B. The stromal component of the marrow microenvironment is not derived from the malignant clone in MDS [letter]. Blood. 2006;108:772-773.
2. Flores-Figueroa E, Arana-Trejo RM, Gutierrez-Espindola G, Perez-Cabrera A, Mayani H. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization. Leuk Res. 2005;29:215-224.
3. Soenen-Cornu V, Tourino C, Bonnet ML, et al. Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro. Oncogene. 2005;24:2441-2448.
4. Awaya N, Rupert K, Bryant E, Torok-Storb B. Marrow stromal cells are not derived from the malignant clone in myelodysplastic syndromes (MDS). Blood. 2001:98:353a. Abstract 1487.
5. Devetten MP, Wenger SL, Wang L, Ericson S, Gibson LF. Trisomy 8 in bone marrow stromal cells in myelodysplastic syndrome. Blood. 2002;100:340b. Abstract 4913.